Revista Pediatría de Atención Primaria 111

Silvia Ibarra Solís, et al . Intervención temprana en las dislipemias: una oportunidad para prevenir la enfermedad cardiovascular Rev Pediatr Aten Primaria. 2026;28:395-405 ISSN: 1139-7632 • www.pap.es 404 BIBLIOGRAFÍA 1. Graham IM, Di Angelantonio E, Visseren F, De Bacquer D, Ference BA, Timmis A, et al . Systematic Coronary Risk Evaluation (SCORE): JACC Focus Seminar 4/8. J AmColl Cardiol. 2021;77(24):3046-57. https://doi.org/10.1016/j.jacc.2021.04.052 2. Schipper HS, de Ferranti S. Atherosclerotic cardiovas- cular risk as an emerging priority in pediatrics. Pediatrics. 2022;150(5):e2022057956. https://doi.org/10.1542/peds.2022-057956 3. Kusters DM, Wiegman A, Kastelein JJP, Hutten BA. Carotid intima-media thickness in children with fa- milial hypercholesterolemia. Circ Res. 2014;114(2):307-10. https://doi.org/10.1161/CIRCRESAHA.114.301430 4. Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, et al . 2026 ACC/AHA/ AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/ PCNA guideline on the management of dyslipide- mia: a report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87(19):2624-757. https://doi.org/10.1016/j.jacc.2025.11.016 5. Wiegman A, Bourbon M, Freiberger T, Gidding SS, Greber-Platzer S, Groselj U, et al . Familial hypercho- lesterolaemia in children and adolescents: a European Atherosclerosis Society consensus state- ment. Eur Heart J. 2026;47(26):3324-46. https://doi.org/10.1093/eurheartj/ehag382 6. Barry MJ, Nicholson WK, Silverstein M, Chelmow D, Coker TR, Davis EM, et al . Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2023;330(3):253-60. https://doi.org/10.1001/jama.2023.11330 7. EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021;398(10312):1713- 25. https://doi.org/10.1016/S0140-6736(21)01122-3 8. Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, et al . 20-year follow-up of statins in children with familial hypercholesterole- mia. N Engl J Med. 2019;381(16):1547-56. https://doi.org/10.1056/NEJMoa1816454 9. National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: full report. Bethesda (MD): National Heart, Lung, and Blood Institute; 2012 [en línea] [con- sultado el 25/09/2026]. Disponible en www.nhlbi. nih.gov/resources/expert-panel-integrated-guideli nes-cardiovascular-health-and-risk-reduction-chil dren-and 10. Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, et al . Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2): e2022060640. https://doi.org/10.1542/peds.2022-060640 11. Peterson AL, Ashraf AP, Bachman J, Hegele RA, Rashad M, South AM, et al . Screening, diagnosis, and mana- gement of pediatric hypertriglyceridemia: a scienti- fic statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2026;46(4):e000195. https://doi.org/10.1161/ATV.0000000000000195 12. Heidemann BE, Koopal C, Baass A, Defesche JC, Zuurbier l, Mulder MT, et al . Establishing the relation- ship between familial dysbetalipoproteinemia and genetic variants in the APOE gene. Clin Genet. 2022;102(4):253-61. https://doi.org/10.1111/cge.14185 13. Burke E, O’Meara M, McGrath N, Griffin D. Sitosterolemia presenting as lipid keratopathy and xanthomas. Pediatrics. 2026;157(2):e2025072657. https://doi.org/10.1542/peds.2025-072657 14. Balwani M, Balistreri W, D’Antiga l, Evans J, Ros E, Abel F, et al . Lysosomal acid lipase deficiency manifesta- tions in children and adults: baseline data from an international registry. Liver Int. 2023;43(7):1537-47. https://doi.org/10.1111/liv.15620 15. Cupido AJ, Tromp TR, Hovingh GK. The clinical appli- cability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspec- tives. Curr Opin Lipidol. 2021;32(2):112-16. https://doi.org/10.1097/MOL.0000000000000741 16. European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration. Familial hypercholesterolaemia in children and ado- lescents from 48 countries: a cross-sectional study. Lancet. 2024;403(10421):55-66. https://doi.org/10.1016/S0140-6736(23)01842-1